Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells

The innate lymphocyte lineage natural killer (NK) is now the target of multiple clinical applications, although none has received an agreement from any regulatory agency yet. Transplant of naïve NK cells has not proven efficient enough in the vast majority of clinical trials. Hence, new protocols wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalba, Martin, Alexia, Catherine, Bellin-Robert, Anais, Fayd'herbe de Maudave, Alexis, Gitenay, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970430/
https://www.ncbi.nlm.nih.gov/pubmed/31998309
http://dx.doi.org/10.3389/fimmu.2019.03026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970430/
https://www.ncbi.nlm.nih.gov/pubmed/31998309
http://dx.doi.org/10.3389/fimmu.2019.03026

Ejemplares similares